ADPT vs ICE · rev $142.4M vs P/E 37, rev $7.28B
Adaptive Biotechnologies Corp (ADPT) versus Intercontinental Exchange Inc (ICE) — a side-by-side from cached financials, not a winner call.
Adaptive Biotechnologies Corp (ADPT) is a diagnostics & research company listed on NASDAQ.
Intercontinental Exchange Inc (ICE) is a financial data & stock exchanges company listed on US.
Latest reported ADPT revenue for 2026-06-30 was $142.4M. Net income was -$59.8M. ADPT currently screens at market cap $2.69B.
Latest reported ICE revenue for 2026-06-30 was $7.28B. Net income was $2.37B. Revenue was up 98.5% from 2026-03-31 to 2026-06-30. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
ADPT currently screens at market cap $2.69B. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
Not investment advice. Open the ADPT and ICE stock pages for the full models.
Not investment advice.